Physician profile
Gary R Bernstein
NPI 1407813579
$1,549.04
in general payments reported to CMS, 2019-2025
17 companies · $566 in 2025
The $566 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $125 · 2021: $24.22 · 2023: $142 · 2024: $339 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $292.57 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Abbvie INC. | $227.00 | 2019-2025 | Skyrizi |
| Madrigal Pharmaceuticals | $168.55 | 2025 | Rezdiffra |
| Lilly USA, LLC | $153.70 | 2024-2025 | Omvoh |
| Janssen Biotech, INC. | $138.18 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Pfizer INC. | $123.14 | 2019-2024 | |
| Intercept Pharmaceuticals, INC. | $116.70 | 2019-2023 | Ocaliva |
| Genzyme Corporation | $94.55 | 2023-2025 | |
| Ironwood Pharmaceuticals, INC | $44.63 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $35.66 | 2024-2025 | Voquezna |
| Shionogi INC | $33.20 | 2019 | |
| Medtronic, INC. | $24.22 | 2021 | |
| Concordia Pharmaceuticals INC. | $23.88 | 2019 | |
| Braintree Laboratories, INC. | $20.79 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.99 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $18.49 | 2024 | Ibsrela |
| Mauna Kea Technologies, INC. | $14.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.